Last updated: February 20, 2026
Magnesium sulfate in plastic containers is a widely used pharmaceutical ingredient, particularly in intravenous (IV) therapy, obstetrics, and dermatology. Major suppliers primarily operate in North America, Europe, and Asia, with specifications aligned to pharmaceutical standards such as USP, EP, and JP.
Global Supply Landscape
| Region |
Key Suppliers |
Production Capacity |
Notable Certifications |
Market Focus |
| North America |
Baxter International, Fresenius Kabi, Kingfisher |
Large scale |
FDA-approved facilities, ISO 13485 |
Hospitals, clinics |
| Europe |
Pfizer, Hikma Pharmaceuticals, B. Braun |
Large scale |
EMA approval, GMP compliant |
Hospital pharmacies, compounding |
| Asia |
Changzhou Siyao Pharmaceutical, Jiangsu Meering, Qilu Pharmaceutical |
Moderate to high |
CFDA approval, GMP standards |
Domestic and export markets |
Key Suppliers
-
Baxter International
Supplies magnesium sulfate for IV therapy in various forms, including sterile plastic containers. Operates worldwide with GMP-compliant manufacturing facilities.
-
Fresenius Kabi
Offers magnesium sulfate solutions in plastic containers, with a focus on infusion therapy products. Holds ISO 13485 and US FDA certifications.
-
Kingfisher
Manufactures magnesium sulfate for pharmaceutical and medical applications, with large-scale production lines in India and the US.
-
Pfizer
Provides magnesium sulfate-related products for hospital use. Facilities are FDA- and EMA-approved.
-
Hikma Pharmaceuticals
Produces magnesium sulfate in sterile plastic packaging, especially in the Middle East and Europe.
-
Changzhou Siyao Pharmaceutical
A leading Chinese manufacturer of magnesium sulfate in plastic containers, with CFDA approval.
-
Jiangsu Meering
Focuses on bulk pharmaceutical ingredients, including magnesium sulfate, with ISO certification.
-
Qilu Pharmaceutical
Supplies magnesium sulfate for hospital and pharmaceutical use across China and exports.
Specification Standards and Quality Certifications
Suppliers align their products with strict regulatory standards:
-
United States Pharmacopeia (USP)
Requirements for purity, strength, and compatibility with IV formulations.
-
European Pharmacopoeia (EP)
Standards for chemical composition and packaging.
-
Japanese Pharmacopoeia (JP)
Applicable for products supplied in Japan and neighboring markets.
Common certifications include:
- Good Manufacturing Practice (GMP)
- ISO 9001 / ISO 13485
- FDA approval (for US markets)
- EMA approval (for European markets)
- CFDA approval (for China)
Market Entry Considerations
-
Regulatory Approvals: Suppliers must meet the country-specific registration requirements, including batch testing and documentation.
-
Packaging Standards: Plastic containers must comply with stability and compatibility standards, often including polycarbonate or polyethylene materials.
-
Pricing and Supply Agreements: Prices vary based on order volume, certification status, and contractual terms.
-
Supply Chain Robustness: Suppliers with Integrated manufacturing and distribution networks face less disruption risks.
Major Market Trends
-
Shift to prefilled containers: Hospitals increasingly favor single-dose, prefilled plastic containers to reduce contamination risks.
-
Regulatory tightening: Stringent quality controls and serialization requirements impact supplier selection.
-
Sourcing diversification: Companies diversify suppliers to mitigate geopolitical and supply chain risks.
Summary
Leading global manufacturers of magnesium sulfate in plastic containers include Baxter, Fresenius Kabi, Kingfisher, Pfizer, Hikma Pharmaceuticals, and several Chinese producers such as Changzhou Siyao Pharmaceutical, Jiangsu Meering, and Qilu Pharmaceutical. Suppliers adhere to internationally recognized standards, with a strong regional presence and varying scales of capacity. Buyers should prioritize GMP certification, regulatory approvals, and supply chain resilience in supplier selection.
Key Takeaways
- Global suppliers for magnesium sulfate in plastic containers operate across North America, Europe, and Asia, with dominant players in each region.
- Major manufacturers include Baxter, Fresenius Kabi, Pfizer, Hikma, and Chinese companies like Changzhou Siyao.
- Product standards satisfy USP, EP, JP, and local regulatory standards, emphasizing quality and safety.
- Market trends favor prefilled containers and stricter regulatory compliance.
- Supply chain stability and supplier certification significantly influence procurement decisions.
FAQs
1. Are there differences in magnesium sulfate products based on container material?
Yes. The most common plastics are polyethylene and polycarbonate, selected for chemical compatibility, stability, and device safety.
2. What certifications are critical for pharmaceutical magnesium sulfate suppliers?
GMP compliance, ISO 13485, FDA approval (for US), and EMA approval (for Europe) are essential.
3. How do Chinese suppliers compare to Western manufacturers?
Chinese suppliers often provide cost-effective options with CE and CFDA certifications, but buyers should verify product quality and regulatory compliance.
4. What are typical lead times for procurement?
Standard lead times range from 4 to 12 weeks, depending on order volume, certification, and logistical factors.
5. How has demand for magnesium sulfate in plastic containers changed recently?
Demand increased due to expanding IV therapy use and hospital protocols favoring prefilled, single-use containers.
References
[1] U.S. Pharmacopeia. (2022). USP Monograph for Magnesium Sulfate.
[2] European Pharmacopoeia. (2021). Magnesium Sulfate Monograph.
[3] Chinese Pharmacopoeia. (2020). Magnesium Sulfate Standards.
[4] Industry Reports. (2022). Global Magnesium Sulfate Market Analysis.
[5] Company Websites: Baxter, Fresenius Kabi, Pfizer, Hikma Pharmaceuticals.
